Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2017, Article ID 1758432, 6 pages
https://doi.org/10.1155/2017/1758432
Research Article

Oxidative Stress Biomarkers: Establishment of Reference Values for Isoprostanes, AOPP, and NPBI in Cord Blood

1Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy
2UOC Clinical Pathology AOU Senese, Siena, Italy

Correspondence should be addressed to Fabrizio Proietti; moc.liamg@3oizirbafitteiorp

Received 28 February 2017; Accepted 19 March 2017; Published 23 April 2017

Academic Editor: Emanuela Turillazzi

Copyright © 2017 Mariangela Longini et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Yoshikawa and Y. Naito, “What is oxidative stress?” Japan Medical Association Journal, vol. 45, no. 7, pp. 271–276, 2002. View at Google Scholar
  2. H. Sies, “Oxidative stress: oxidants and antioxidants,” Experimental Physiology, vol. 82, no. 2, pp. 291–295, 1997. View at Publisher · View at Google Scholar
  3. S. Nikam, P. Nikam, S. Ahaley, and A. Sontakke, “Oxidative stress in Parkinson’s disease,” Indian Journal of Clinical Biochemistry, vol. 24, no. 1, pp. 98–101, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. C. Zhou, Y. Huang, and S. Przedborski, “Oxidative stress in Parkinson’s disease: a mechanism of pathogenic and therapeutic significance,” Annals of the new York Academy of Sciences, vol. 1147, pp. 93–104, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. G. J. Handelman, “Evaluation of oxidant stress in dialysis patients,” Blood Purification, vol. 18, no. 4, pp. 343–349, 2000. View at Publisher · View at Google Scholar
  6. S. Perrone, M. L. Tataranno, S. Negro et al., “Early identification of the risk for free radical-related diseases in preterm newborns,” Early Human Development, vol. 86, no. 4, pp. 241–244, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Perrone, M. L. Tataranno, and G. Buonocore, “Oxidative stress and broncopulmonary dysplasia,” Journal of Clinical Neonatology, vol. 1, no. 3, pp. 109–114, 2012. View at Publisher · View at Google Scholar
  8. S. Perrone, P. Vezzosi, M. Longini et al., “Biomarkers of oxidative stress in babies at high risk for retinopathy of prematurity,” Frontiers in Bioscience (Elite Edition), vol. 1, no. 2, pp. 547–552, 2009. View at Google Scholar
  9. S. Perrone, M. L. Tataranno, S. Negro et al., “May oxidative stress biomarkers in cord blood predict the occurrence of necrotizing enterocolitis in preterm infants?” The Journal of Maternal-Fetal & Neonatal Medicine, vol. 25, Supplement 1, pp. 128–131, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Buonocore, S. Perrone, M. Longini et al., “Non protein bound iron as early predictive marker of neonatal brain damage,” Brain, vol. 126, Part 5, pp. 1224–1230, 2003. View at Publisher · View at Google Scholar
  11. S. Perrone, M. L. Tataranno, G. Stazzoni, and G. Buonocore, “Biomarkers of oxidative stress in fetal and neonatal diseases,” The Journal of Maternal-Fetal & Neonatal Medicine, vol. 25, no. 12, pp. 2575–2578, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. G. S. Berkowitz and E. Papiernik, “Epidemiology of preterm birth,” Epidemiologic Reviews, vol. 15, no. 2, pp. 414–443, 1993. View at Publisher · View at Google Scholar
  13. O. P. Mishra and M. Delivoria-Papadopoulos, “Cellular mechanisms of hypoxic injury in the developing brain,” Brain Research Bulletin, vol. 48, no. 3, pp. 233–238, 1999. View at Publisher · View at Google Scholar · View at Scopus
  14. B. H. Yoon, R. Romero, J. K. Jun et al., “Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia,” American Journal of Obstetrics and Gynecology, vol. 177, no. 4, pp. 825–830, 1997. View at Publisher · View at Google Scholar
  15. W. W. Andrews, R. L. Goldenberg, O. Faye-Petersen, S. Cliver, A. R. Goepfert, and J. C. Hauth, “The Alabama preterm birth study: polymorphonuclear and mononuclear cell placental infiltrations, other markers of inflammation, and outcomes in 23- to 32-week preterm newborn infants,” American Journal of Obstetrics and Gynecology, vol. 195, no. 3, pp. 803–808, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. R. M. Blumberg, E. B. Cady, J. S. Wigglesworth, J. E. McKenzie, and A. D. Edwards, “Relation between delayed impairment of cerebral energy metabolism and infarction following transient focal hypoxia-ischaemia in the developing brain,” Experimental Brain Research, vol. 113, no. 1, pp. 130–137, 1997. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Ciccoli, V. Rossi, S. Leoncini et al., “Iron release in erythrocytes and plasma non protein-bound iron in hypoxic and non hypoxic newborns,” Free Radical Research, vol. 37, no. 1, pp. 51–58, 2003. View at Google Scholar
  18. S. Frosali, P. Di Simplicio, S. Perrone et al., “Glutathione recycling and antioxidant enzyme activities in erythrocytes of term and preterm newborns at birth,” Biology of the Neonate, vol. 85, no. 3, pp. 188–194, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Vento, M. Asensi, J. Sastre, F. García-Sala, and J. Viña, “Six years of experience with the use of room air resuscitation of asphyxiated newly born term infants,” Biology of the Neonate, vol. 79, no. 3–4, pp. 261–267, 2001. View at Publisher · View at Google Scholar
  20. G. Barreto, D. Madureira, F. Capani, L. Aon-Bertolino, E. Saraceno, and L. D. Alvarez-Giraldez, “The role of catechols and free radicals in benzene toxicity: an oxidative DNA damage pathway,” Environmental and Molecular Mutagenesis, vol. 50, no. 9, pp. 771–780, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. R. M. Adibhatla and J. F. Hatcher, “Phospholipase A(2), reactive oxygen species, and lipid peroxidation in CNS pathologies,” BMB Reports, vol. 41, no. 8, pp. 560–567, 2008. View at Publisher · View at Google Scholar
  22. M. C. Gongora, H. E. Lob, U. Landmesser et al., “Loss of extracellular superoxide dismutase leads to acute lung damage in the presence of ambient air: a potential mechanism underlying adult respiratory distress syndrome,” The American Journal of Pathology, vol. 173, no. 4, pp. 915–926, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Wang, S. Fasciano, and L. Li, “The interleukin-1 receptor associated kinase 1 contributes to the regulation of NFAT,” Molecular Immunology, vol. 45, no. 15, pp. 3902–3908, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. P. Paffetti, S. Perrone, M. Longini et al., “Non-protein-bound iron detection in small samples of biological fluids and tissues,” Biological Trace Element Research, vol. 112, no. 3, pp. 221–232, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Buonocore, S. Perrone, M. Longini, L. Terzuoli, and R. Bracci, “Total hydroperoxide and advanced oxidation protein products in preterm hypoxic babies,” Pediatric Research, vol. 47, no. 2, pp. 221–224, 2000. View at Publisher · View at Google Scholar
  26. G. Tonni, S. Leoncini, C. Signorini, L. Ciccoli, and C. De Felice, “Pathology of perinatal brain damage: background and oxidative stress markers,” Archives of Gynecology and Obstetrics, vol. 290, no. 1, pp. 13–20, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. K. S. Leung, J. M. Galano, T. Durand, and J. C. Lee, “Current development in non-enzymatic lipid peroxidation products, isoprostanoids and isofuranoids, in novel biological samples,” Free Radical Research, vol. 79, no. 7, pp. 816–826, 2015. View at Google Scholar
  28. U. Jahn, J. M. Galano, and T. Durand, “Beyond prostaglandins: chemistry and biology of cyclic oxygenated metabolites formed by free-radical pathways from polyunsaturated fatty acids,” Angewandte Chemie (International Ed. In English), vol. 47, no. 32, pp. 5894–5955, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. J. M. Galano, E. Mas, A. Barden et al., “Isoprostanes and neuroprostanes: total synthesis, biological activity and biomarkers of oxidative stress in humans,” Prostaglandins & Other Lipid Mediators, vol. 107, pp. 95–102, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Casetta, M. Longini, F. Proietti, S. Perrone, and G. Buonocore, “Development of a fast and simple LC-MS/ MS method for measuring the F2-isoprostanes in newborns,” The Journal of Maternal-Fetal & Neonatal Medicine, vol. 25, Supplement 1, pp. 114–118, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. S. Basu, “F2-isoprostanes in human health and diseases: from molecular mechanisms to clinical implications,” Antioxidants & Redox Signaling, vol. 10, no. 8, pp. 1405–1434, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Papanikolaou and K. Pantopoulos, “Iron metabolism and toxicity,” Toxicology and Applied Pharmacology, vol. 202, no. 2, pp. 199–211, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Buonocore, S. Perrone, M. Longini et al., “Oxidative stress in preterm neonates at birth and on the seventh day of life,” Pediatric Research, vol. 52, no. 1, pp. 46–49, 2002. View at Publisher · View at Google Scholar
  34. CLSI/NCCLS, Procedures for the Handling and Processing of Blood Specimens; Approved Guideline—Third Edition. CLSI/NCCLS Document H18-A3, NCCLS, Wayne, PA, 2004.
  35. V. Witko-Sarsat, M. Friedlander, C. Capeillère-Blandin et al., “Advanced oxidation protein products as a novel marker of oxidative stress in uremia,” Kidney International, vol. 49, no. 5, pp. 1304–1313, 1996. View at Publisher · View at Google Scholar
  36. P. S. Horn and A. J. Pesce, Reference Intervals. A User’s Guide, AACC Press, Washington, DC, 2005.
  37. CLSI, Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline—Third Edition. CLSI Document EP28-A3c, Wayne, PA, Clinical and Laboratory Standards Institute, 2008.
  38. K. Schnabl, M. K. Chan, Y. Gong, and K. Adeli, “Closing the gaps in paediatric reference intervals: the CALIPER initiative,” Clinical Biochemist Reviews, vol. 29, no. 3, pp. 89–96, 2008. View at Google Scholar
  39. Y. O. Ilcol and D. Aslan, “Use of total patient data for indirect estimation of reference intervals for 40 clinical chemical analytes in Turkey,” Clinical Chemistry and Laboratory Medicine, vol. 44, no. 7, pp. 867–876, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. F. Tang, S. Messinger, and C. Cray, “Use of an indirect sampling method to produce reference intervals for hematologic and biochemical analyses in Psittaciform species,” Journal of Avian Medicine and Surgery, vol. 27, no. 3, pp. 194–203, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. P. S. Horn, L. Feng, Y. Li, and A. J. Pesce, “Effect of outliers and nonhealthy individuals on reference interval estimation,” Clinical Chemistry, vol. 47, no. 12, pp. 2137–2145, 2001. View at Google Scholar
  42. A. H. Reed, R. J. Henry, and W. B. Mason, “Influence of statistical method used on the resulting estimate of normal range,” Clinical Chemistry, vol. 17, no. 4, pp. 275–284, 1971. View at Google Scholar
  43. K. Linnet, “Two-stage transformation systems for normalization of reference distributions evaluated,” Clinical Chemistry, vol. 33, no. 3, pp. 381–386, 1987. View at Google Scholar
  44. B. Efron, The Jackknife, the Bootstrap and Other Resampling Plans, Society for Industrial and Applied Mathematics, Philadelphia, PA, 1982.